Safety Study of Tasimelteon for Treatment of Non-24-Hour-Sleep-Wake Disorder in Blind Individuals With No Light Perception
Clinical trial NCT01218789 · UNKNOWN
Trial details
- NCT number
- NCT01218789
- Sponsor
- Vanda Pharmaceuticals
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-28
- Primary completion
- 2024-12-05
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.